vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Smith Douglas Homes Corp. is the larger business by last-quarter revenue ($260.4M vs $207.8M, roughly 1.3× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 1.4%, a 56.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $8.7M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
IDYA vs SDHC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $260.4M |
| Net Profit | $119.2M | $3.5M |
| Gross Margin | — | 19.9% |
| Operating Margin | 52.2% | 6.5% |
| Net Margin | 57.4% | 1.4% |
| Revenue YoY | — | -9.4% |
| Net Profit YoY | 330.1% | -14.3% |
| EPS (diluted) | $1.33 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $260.4M | ||
| Q3 25 | $207.8M | $262.0M | ||
| Q2 25 | — | $223.9M | ||
| Q1 25 | — | $224.7M | ||
| Q4 24 | — | $287.5M | ||
| Q3 24 | $0 | $277.8M | ||
| Q2 24 | $0 | $220.9M | ||
| Q1 24 | $0 | $189.2M |
| Q4 25 | — | $3.5M | ||
| Q3 25 | $119.2M | $2.1M | ||
| Q2 25 | — | $2.4M | ||
| Q1 25 | — | $2.7M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | $-51.8M | $5.3M | ||
| Q2 24 | $-52.8M | $3.6M | ||
| Q1 24 | $-39.6M | $3.0M |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | — | 6.5% | ||
| Q3 25 | 52.2% | 6.6% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 11.7% | ||
| Q1 24 | — | 11.3% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 57.4% | 0.8% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | $0.39 | ||
| Q3 25 | $1.33 | $0.24 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.30 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | $-0.60 | $0.58 | ||
| Q2 24 | $-0.68 | $0.40 | ||
| Q1 24 | $-0.53 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $12.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $86.7M |
| Total Assets | $1.2B | $557.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $12.7M | ||
| Q3 25 | $786.9M | $14.8M | ||
| Q2 25 | — | $16.8M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | $920.0M | $23.7M | ||
| Q2 24 | $701.7M | $17.3M | ||
| Q1 24 | $698.8M | $32.8M |
| Q4 25 | — | $86.7M | ||
| Q3 25 | $1.1B | $82.2M | ||
| Q2 25 | — | $80.0M | ||
| Q1 25 | — | $76.9M | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | $1.2B | $68.4M | ||
| Q2 24 | $931.7M | $62.1M | ||
| Q1 24 | $935.3M | $59.7M |
| Q4 25 | — | $557.6M | ||
| Q3 25 | $1.2B | $571.6M | ||
| Q2 25 | — | $570.2M | ||
| Q1 25 | — | $513.9M | ||
| Q4 24 | — | $475.9M | ||
| Q3 24 | $1.2B | $460.1M | ||
| Q2 24 | $973.7M | $429.3M | ||
| Q1 24 | $961.5M | $401.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $9.8M |
| Free Cash FlowOCF − Capex | $142.2M | $8.7M |
| FCF MarginFCF / Revenue | 68.4% | 3.4% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | 1.19× | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.8M | ||
| Q3 25 | $142.2M | $22.8M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $-34.9M | ||
| Q4 24 | — | $5.5M | ||
| Q3 24 | $-49.2M | $22.9M | ||
| Q2 24 | $-32.9M | $39.0K | ||
| Q1 24 | $-43.8M | $-9.3M |
| Q4 25 | — | $8.7M | ||
| Q3 25 | $142.2M | $21.4M | ||
| Q2 25 | — | $-31.1M | ||
| Q1 25 | — | $-35.9M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | $-49.7M | $22.3M | ||
| Q2 24 | $-33.9M | $-2.1M | ||
| Q1 24 | $-45.1M | $-9.7M |
| Q4 25 | — | 3.4% | ||
| Q3 25 | 68.4% | 8.2% | ||
| Q2 25 | — | -13.9% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | -1.0% | ||
| Q1 24 | — | -5.1% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | — | 2.77× | ||
| Q3 25 | 1.19× | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | — | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
